Neuroscience Focus Areas:
Our other therapy areas

    • {%buzitemName%}
        {%buzbrandMenuItems%}
    • {%bitemName%} {%barrowSpan%}
        {%bsubBrandMenuItems%}
    • {%sbitemName%} {%sbarrowSpan%}
        {%sbproductMenuItems%}
    • {%pitemKeyName%} {%pitemBadges%} {%parrowSpan%}
      {%pselfProduct%}
    • {%mNavitemName%}
      • {%lScountries%}
    • {%allMenuItem%}
      • {%cSlanguages%}

      • This website is for UK Healthcare Professionals only

      This promotional material is intended for UK Healthcare Professionals (HCPs) experienced in the diagnosis and management of Parkinson’s disease only. Adverse event reporting can be found below

      Prescribing Information Link
      Summary of Product Characteristics Link

      PRODUODOPA (foslevodopa/foscarbidopa solution for infusion) is indicated for the treatment of advanced levodopa-responsive Parkinson’s disease (PD) with severe motor fluctuations and hyperkinesia or dyskinesia when available combinations of Parkinson’s medicinal products have not given satisfactory results.1
       

      Because levodopa may activate malignant melanoma, PRODUODOPA should not be used in patients with suspicious undiagnosed skin lesions or a history of melanoma.
       
      Prescribing Information Link
      Summary of Product Characteristics Link

      PRODUODOPA (foslevodopa/foscarbidopa solution for infusion) is indicated for the treatment of advanced levodopa-responsive Parkinson’s disease (PD) with severe motor fluctuations and hyperkinesia or dyskinesia when available combinations of Parkinson’s medicinal products have not given satisfactory results.1

      Because levodopa may activate malignant melanoma, PRODUODOPA should not be used in patients with suspicious undiagnosed skin lesions or a history of melanoma.

      Some patients may not be suitable for PRODUODOPA. You are strongly advised to read the Prescribing Information (PI), and Summary of Product Characteristics (SmPC) which can be found via the links above, to evaluate patient suitability for PRODUODOPA.

      Banner displaying a brain graphic with the title exPloreD
      Banner displaying a brain graphic with the title exPloreD

      The promotional events are intended for UK healthcare professionals experienced in the diagnosis and management of advanced Parkinson's disease only.
      They have been organised and funded by AbbVie, including payment of speaker honoraria, and will contain information about Produodopa®

      Promotional Masterclass and Optional Training Meeting

      This promotional meeting is intended for UK healthcare professionals experienced in the diagnosis and management of Parkinson’s disease only.

      This promotional meeting has been organised and funded by Abbie, including payment of speaker honoraria, and will contain information about AbbVie products.

      You may choose to attend the Masterclass only (Day 1 and morning of Day 2) or the full programme, including optional training in the afternoon of Day 2.

      AbbVie invites you to register for this educational promotional masterclass, where you will have the opportunity to learn more about the role of Produodopa® in clinical practice for advanced Parkinson's Disease. The sessions will cover topics such as patient identification, on-going management and service considerations with a panel of experts and interactive workshops.

      An optional training session will provide practical guidance on the Produodopa® infusion system and portable Vyafuser® pump, including setup and dose programming.

      Promotional Masterclass and Optional Training Meeting

      This promotional meeting is intended for UK healthcare professionals experienced in the diagnosis and management of Parkinson’s disease only.

      This promotional meeting has been organised and funded by Abbie, including payment of speaker honoraria, and will contain information about AbbVie products.

      You may choose to attend the Masterclass only (Day 1 and morning of Day 2) or the full programme, including optional training in the afternoon of Day 2.

      AbbVie invites you to register for this educational promotional masterclass, where you will have the opportunity to learn more about the role of Produodopa® in clinical practice for advanced Parkinson's Disease. The sessions will cover topics such as patient identification, on-going management and service considerations with a panel of experts and interactive workshops.

      An optional training session will provide practical guidance on the Produodopa® infusion system and portable Vyafuser® pump, including setup and dose programming.

      Circular graphic split into two teal shades with a calendar illustration in the center with March in white text

      exPloreD Masterclass

      Date: Wednesday 4th and Thursday 5th November 2026
      Time:       Wednesday 4th November from 10:00 to 17:00
      Thursday 5th November from 09:00 to 12:00
      Location:       Hilton London Paddington - 146 Praed St, London W2 1EE 

      Objectives:

      • Explore the role of Produodopa® in the management of patients with advanced PD
      • Discuss the role of the multidisciplinary team when initiating Produodopa® and managing patients
      • Learn from colleagues’ experience through knowledge exchange and sharing of best practice
      Circular graphic split into two teal shades with a calendar illustration in the center with March in white text

      exPloreD Masterclass

      Date: Wednesday 4th and Thursday 5th November 2026
      Time:       Wednesday 4th November from 10:00 to 17:00
      Thursday 5th November from 09:00 to 12:00
      Location:       Hilton London Paddington - 146 Praed St, London W2 1EE 

      Objectives:

      • Explore the role of Produodopa® in the management of patients with advanced PD
      • Discuss the role of the multidisciplinary team when initiating Produodopa® and managing patients
      • Learn from colleagues’ experience through knowledge exchange and sharing of best practice
      Circular graphic split into two teal shades with a calendar illustration in the center with March in white text

      Optional training

      Date: Thursday 5th November 2026
      Time:       13:00 to 16:00
      Location:       Hilton London Paddington - 146 Praed St, London W2 1EE 

      Objectives:

      • Feel confident in your knowledge of the Produodopa® infusion system and the portable Vyafuser® pump
      • Be able to demonstrate the steps that your patients will need to go through to set up their Produodopa® infusion
      • Understand how to calculate and programme the hourly infusion rate, loading dose, and extra dose functions
      • Be aware of the resources available to support you and your patients using Produodopa®
      Circular graphic split into two teal shades with a calendar illustration in the center with March in white text

      Optional training

      Date: Thursday 5th November 2026
      Time:       13:00 to 16:00
      Location:       Hilton London Paddington - 146 Praed St, London W2 1EE 

      Objectives:

      • Feel confident in your knowledge of the Produodopa® infusion system and the portable Vyafuser® pump
      • Be able to demonstrate the steps that your patients will need to go through to set up their Produodopa® infusion
      • Understand how to calculate and programme the hourly infusion rate, loading dose, and extra dose functions
      • Be aware of the resources available to support you and your patients using Produodopa®
      Register now
      Register now

      Accommodation is available on Tuesday 3 November 2026 for delegates travelling more than 3 hours to the venue, to ensure timely arrival.

      Please note, your details will only be used for the purpose of communication for this meeting and will not be retained. Please email exploredPD@ashleycomms.com if you have any queries regarding this meeting.

      Please refer to the PRODUODOPA SmPC for further information on adverse events, contraindications and special warnings and precautions for use.

      Resources

      References

      1. PRODUODOPA (foslevodopa/foscarbidopa solution for infusion) Summary of Product Characteristics.
      PRODUODOPA PRESCRIBING INFORMATION

      By clicking the link above you will leave the AbbVie Pro website and be taken to the eMC PI portal website

      Adverse events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk.

      Adverse events should also be reported to AbbVie on GBPV@abbvie.com

      UK-PRODD-260259. Date of preparation: July 2026.

      Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or via the MHRA Yellow Card app, available in the Google Play or Apple App Stores. Adverse events should also be reported to AbbVie on GBPV@abbvie.com

       

      This website is for UK Healthcare Professionals only

      UK-ABBV-250400. Date of preparation December 2025. This website has been developed and funded by AbbVie Ltd.

      © 2023 AbbVie Ltd. All rights reserved. Registered Number: 08004972 England.